Pharmafile Logo

Vaccine hesitancy eBook

June 7, 2021 | #COVID19, coronavirus, vaccines 

In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake.

- PMLiVEToday, all eyes are on vaccines. At its high, the US administered 3.4 million doses of the COVID-19 vaccines per day, but in April, this number dwindled to 2.2 million per day. The vulnerable and those who passionately support the vaccines had queued up to become the first to be immunized, sometimes driving hours to get their shot.

However, now that the most enthusiastic populations have been vaccinated, life science companies, healthcare professionals, and the government are up against the challenging task of coaxing the 31% of Americans who are vaccine-hesitant into signing up for the vaccine.

States, corporations, and vaccination centers are even offering incentives from doughnuts and free beer, to savings bonds and marijuana to stimulate demand for vaccines.

In this downloadable pack, we interview industry-leading stakeholders and provide expert analysis from our consultants and commercial experts. Download the PDF to explore:

  • Original research findings on the deeper drivers behind vaccine hesitancy and the benefits of taking a human-centred approach for increasing vaccine uptake
  • The current landscape, expert analysis, and advice for improving vaccine uptake
  • The motivations behind the Arm in Arm campaign, a global campaign designed to encourage donations to ensure everyone across the globe has access to a lifesaving COVID-19 vaccine
  • The social and political drivers fuelling the anti-vax movement
  • The differences between the US and UK immunization programs
  • Why our consultants are volunteering to be part of the UK immunization program

DOWNLOAD THE EBOOK HERE

This content was provided by Avalere Health

Company Details

 Latest Content from  Avalere Health 

6 trends shaping the future of personalized medicine

Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

The Evolving Role of the Sales Rep

The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...

Measure your omnichannel maturity with our new tool

Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness.

Report: Omnichannel advice for the life science industry

In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...

6 trends shaping the future of personalized medicine

Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

Omnichannel strategies to revolutionize the healthcare professional experience

Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...

The digital-first launch: the key to connected stakeholder experiences?

During the COVID-19 pandemic, a new digital-first launch model emerged as a gamechanger for driving better customer experiences. Here, Senior Consultant Srividya Sekar; Senior Associate Consultant, Erin Johnstone; and Associate...

Learning and development: the secret weapon for a successful life science launch

Dave Stuteville, Executive Vice President, Learning & Development, reveals the principles behind successfully training Sales Representatives and Medical Science Liaisons for a rapid biopharmaceutical product launch.

Data-driven policy and market access firm Avalere joins Fishawack Health

Fishawack Health bolsters its commercialization service offering with its largest addition to date, welcoming US-based policy, market access, and transformation leader Avalere.

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...